Skip to main content

Briefly Bio

Briefly, Bio provides a platform for concise, factual company descriptions based on provided web content. It distills essential business information into a three-sentence, keyword-rich summary. This service ensures rapid understanding of a company's core value proposition without extraneous detail.

Traction 10/10
London, United Kingdom · HQ
Founded 202241K+ followers
  • Artificial Intelligence
  • Data & Analytics
  • Biotechnology
  • Enterprise Software
  • Healthcare Technology
  • Software Only
Updated 21 months ago

Funding

Raised to date

$1.2MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

3 founders

Harry Rickerby

CEO

Katya Putintseva

Co-founder

Staffan Piledahl

Co-founder

Product

Problem

Scientists often struggle to translate experimental designs into executable protocols for automated lab equipment, leading to inefficiencies and underutilization of automation resources. The iterative process of communicating experimental intent to engineers and resolving incompatibilities can be time-consuming and error-prone. Furthermore, maintaining comprehensive traceability across both automated and manual lab work is challenging.

Solution

Briefly Bio provides a natural language interface that bridges the gap between scientists and lab automation systems. The platform translates scientists' experimental intent, expressed in natural language, into instructions compatible with automated systems. It highlights missing details and incompatibilities early in the design process, reducing back-and-forth communication with engineers. Briefly Bio also integrates automated and manual lab work into a unified format, ensuring full traceability. The platform facilitates the reuse of protocols across different automation systems by seamlessly transforming them from one system to another.

Target Audience

The primary target audience includes biotech scientists and research organizations seeking to streamline experiment design, improve lab automation utilization, and enhance reproducibility.

Features

  • Natural language processing (NLP) for translating experimental intent into automation commands
  • Compatibility checks to identify missing details and incompatibilities in real-time
  • Unified platform for managing both automated and manual lab work
  • Protocol transformation for seamless reuse across different automation systems
  • Visual experiment builder for creating clear and consistent experimental plans
  • AI copilot to automate repetitive tasks and streamline experiment design
  • Automated plate map generation
  • Integration with liquid handlers
This profile is AI-generated and may contain inaccuracies.